Studies indicate that diabetes can adversely affect CRC prognosis [10], suggesting that pharmacological or lifestyle interventions aimed at reducing insulin levels may be effective in preventing CRC tumorigenesis [11]. Here, INS is linked to colorectal carcinoma.